-
SLN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
Silence Therapeutics (SLN)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 70 |
Opened positions | 69 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 485.26 bn |
Total shares | 34.61 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Artal International S.C.A. | 7.50 mm | $64.58 mm |
TCG Crossover Management | 3.30 mm | $62.61 bn |
Artal | 2.78 mm | $52.81 bn |
Lombard Odier Asset Management | 2.41 mm | $36.76 bn |
Redmile | 2.01 mm | $38.27 bn |
Logos Global Management | 1.48 mm | $28.05 bn |
Deep Track Capital | 1.36 mm | $25.84 bn |
Frazier Life Sciences Management | 1.15 mm | $21.82 bn |
Vivo Capital | 1.11 mm | $21.00 bn |
Nextech Invest | 952.40 k | $18.10 bn |